Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

A new treatment option for treatment-emergent central apnea syndrome: a case series

S Şahin Duyar, S Fırat
ERJ Open Research 2021 7: 7; DOI: 10.1183/23120541.sleepandbreathing-2021.7
S Şahin Duyar
University of Health Sciences Atatürk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Fırat
University of Health Sciences Atatürk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Introduction: Most of the patients with treatment-emergent central apnea syndrome (TECSA) experience resolution of central apneas after 2-3 months of CPAP treatment. For patients who do not respond to CPAP therapy, BPAP-ST or ASV modes are recommended. The aim of this case series is to show the efficacy of APAP (automatic positive airway pressure) devices in the management of TECSA.

Methods: In this case series, the clinical features and treatment results of 5 male patients who started using APAP (automatic positive airway pressure) devices for TECSA treatment in our clinic during 2019 were retrospectively analyzed.

Results: The clinical characteristics and treatment results of the patients are summarized in Tables 1 and 2. Two patients used an APAP device with a forced oscillation technique (FOT) and the others used APAP devices that could differentiate central apneas using the obstructive pressure peak (OPP) method. In Patient 1, even in the second week of the treatment, total regression of the central events was evident, while longer-term treatment results were also successful in the other patients.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Discussion and Conclusion: APAP devices are constantly updated. The new algorithms including FOT / OPP differentiate central apneas more effectively and prevent unnecessary increases in pressure. APAP devices with these new algorithms can be a treatment option in TECSA.

  • Central sleep apnoea
  • Positive pressure therapy (incl CPAP and NIV modes)

Footnotes

Cite this article as ERJ Open Research 2021; 7: Suppl. 7, 7.

This is an ERS Lung Science Conference abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Next
Back to top
Vol 7 Issue suppl 7 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A new treatment option for treatment-emergent central apnea syndrome: a case series
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A new treatment option for treatment-emergent central apnea syndrome: a case series
S Şahin Duyar, S Fırat
ERJ Open Research Apr 2021, 7 (suppl 7) 7; DOI: 10.1183/23120541.sleepandbreathing-2021.7

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A new treatment option for treatment-emergent central apnea syndrome: a case series
S Şahin Duyar, S Fırat
ERJ Open Research Apr 2021, 7 (suppl 7) 7; DOI: 10.1183/23120541.sleepandbreathing-2021.7
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP
  • Epworth Sleepiness Scale and NoSAS score as screening tools for Obstructive Sleep Apnea (OSA)
  • Association between sleep-disordered breathing and MRI-based brain iron content
Show more Sleep & Breathing disorders

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society